新疆医科大学学报
新疆醫科大學學報
신강의과대학학보
JOURNAL OF XINJIANG MEDICAL UNIVERSITY
2015年
9期
1135-1137
,共3页
樊勤学%阿布力米提·阿木提%徐江波
樊勤學%阿佈力米提·阿木提%徐江波
번근학%아포력미제·아목제%서강파
依托考昔%氨基葡萄糖%骨性关节炎
依託攷昔%氨基葡萄糖%骨性關節炎
의탁고석%안기포도당%골성관절염
Etoricoxib%Glucosamine%osteoarthritis
目的:探讨依托考昔联合氨基葡萄糖治疗中、重度膝关节骨性关节炎的临床疗效及其临床应用价值。方法将106例中、重度膝关节骨性关节炎患者随机分为对照组(单纯应用依托考昔)和治疗组(依托考昔+氨基葡萄糖),连续治疗4 w。对两组患者治疗前后 VAS 评分及 Lysholm 评分变化进行统计学分析,并计算其临床总有效率。结果治疗4 w 后,两组患者 VAS 评分较治疗前明显降低,Lysholm 评分均较治疗前明显升高(P 均<0.05),治疗组的效果优于对照组;对照组总有效率为88.89%,治疗组总有效率为92.30%,差异有统计学意义(P<0.05)。结论依托考昔联合氨基葡萄糖治疗中、重度膝关节骨性关节炎临床疗效显著,患者疼痛缓解两组VAS 评分相近,改善膝关节功能疗效优于单纯依托考昔。
目的:探討依託攷昔聯閤氨基葡萄糖治療中、重度膝關節骨性關節炎的臨床療效及其臨床應用價值。方法將106例中、重度膝關節骨性關節炎患者隨機分為對照組(單純應用依託攷昔)和治療組(依託攷昔+氨基葡萄糖),連續治療4 w。對兩組患者治療前後 VAS 評分及 Lysholm 評分變化進行統計學分析,併計算其臨床總有效率。結果治療4 w 後,兩組患者 VAS 評分較治療前明顯降低,Lysholm 評分均較治療前明顯升高(P 均<0.05),治療組的效果優于對照組;對照組總有效率為88.89%,治療組總有效率為92.30%,差異有統計學意義(P<0.05)。結論依託攷昔聯閤氨基葡萄糖治療中、重度膝關節骨性關節炎臨床療效顯著,患者疼痛緩解兩組VAS 評分相近,改善膝關節功能療效優于單純依託攷昔。
목적:탐토의탁고석연합안기포도당치료중、중도슬관절골성관절염적림상료효급기림상응용개치。방법장106례중、중도슬관절골성관절염환자수궤분위대조조(단순응용의탁고석)화치료조(의탁고석+안기포도당),련속치료4 w。대량조환자치료전후 VAS 평분급 Lysholm 평분변화진행통계학분석,병계산기림상총유효솔。결과치료4 w 후,량조환자 VAS 평분교치료전명현강저,Lysholm 평분균교치료전명현승고(P 균<0.05),치료조적효과우우대조조;대조조총유효솔위88.89%,치료조총유효솔위92.30%,차이유통계학의의(P<0.05)。결론의탁고석연합안기포도당치료중、중도슬관절골성관절염림상료효현저,환자동통완해량조VAS 평분상근,개선슬관절공능료효우우단순의탁고석。
Objective To observe clinical efficacy and value of Etoricoxib combined with glucosamine treat-ment of moderate to severe knee osteoarthritis.Methods 106 patients with moderate to severe osteoarthri-tis of the knee were randomly divided into control group (simple application of Etoricoxib)and treatment group (Etoricoxib+Glucosamine),continuous treatment 4 weeks.The statistical analysis was applied in the two groups of patients before and after treatment VAS score and Lysholm score changes,and the rates of total clinical effectiveness were calculated.Results After 4 weeks treatment,the two groups were sig-nificantly lower VAS scores,Lysholm score treatment group was significantly better than those of the control group,and the difference was statistically significant (P <0.05).Conclusion It showed that the clinically significant effects in Etoricoxib combined with Glucosamine treatment of moderate to severe knee osteoarthritis,relieve pain similar in both groups of patients,improve the efficacy of knee function better than Etoricoxib.